共 22 条
[2]
Ghanim Husam,Batra Manav,Green Kelly,Abuaysheh Sanaa,Hejna Jeanne,Makdissi Antione,Borowski Robert,Kuhadiya Nitesh D,Chaudhuri Ajay,Dandona Paresh.Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss[J].Diabetes, obesity & metabolism,2020
[3]
Dejgaard Thomas F,Schmidt Signe,Frandsen Christian S,Vistisen Dorte,Madsbad Sten,Andersen Henrik U,Nørgaard Kirsten.Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial[J].Diabetes, obesity & metabolism,2020
[5]
Jana Urbanova,Ludmila Brunerova,Jan Broz.Hypoglycemia and antihyperglycemic treatment in adult MODY patients – A systematic review of literature[J].Diabetes Research and Clinical Practice,2019
[6]
Lee Gung,Jang Hagoon,Kim Ye Young,Choe Sung Sik,Kong Jinuk,Hwang Injae,Park Jeu,Im Seung-Soon,Kim Jae Bum.SREBP1c-PAX4 Axis Mediates Pancreatic β Cell Compensatory Responses Upon Metabolic Stress[J].Diabetes,2018
[7]
Kanako Tamura,Kohtaro Minami,Maya Kudo,Keisuke Iemoto,Harumi Takahashi,Susumu Seino.Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice[J].PLoS ONE,2017
[8]
Açiksari Ayşegül,Duruksu Gökhan,Karaöz Erdal.Improved insulin-secreting properties of pancreatic islet mesenchymal stem cells by constitutive expression of Pax4 and MafA[J].Turkish journal of biology = Turk biyoloji dergisi,2017
[9]
Petruzelkova L,Dusatkova P,Cinek O,Sumnik Z,Pruhova S,Hradsky O,Vcelakova J,Lebl J,Kolouskova S.Substantial proportion of MODY among multiplex families participating in a Type 1 diabetes prediction programme[J].Diabetic medicine : a journal of the British Diabetic Association,2016